Latest Intelliject Inc. Stories
RICHMOND, Va., Aug. 1, 2011 /PRNewswire/ -- Intelliject, Inc. today announced that the U.S.
RICHMOND, Va., Nov. 30 /PRNewswire/ -- Intelliject, Inc. today announced an exclusive license with sanofi-aventis U.S. for a novel epinephrine auto-injector, in the U.S. and Canada territory. Under the license, sanofi-aventis U.S. shall be responsible for manufacturing and commercialization.
BRIDGEWATER, N.J., Nov. 30 /PRNewswire-FirstCall/ -- Sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis) in North America (U.S. and Canada).
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.